March 2023 - Page 4 of 4 - BioMedWire (BMW)

FridayMar 03, 2023 10:30 am

India Globalization Capital Inc. (NYSE American: IGC) Leads the Way Forward with Revolutionary Cannabis-Based Treatment for Alzheimer’s Symptoms

Company’s investigational drug is being tested for the first time ever on humans in an FDA-approved study In phase 1 studies, IGC-AD1 shows potential to safely reduce debilitating symptoms IGC is actively building a portfolio of both cannabis-based and manufactured molecules that can address multiple areas of unmet medical needs In groundbreaking work that establishes its commitment to being a pioneer in the treatment of Alzheimer’s disease, India Globalization Capital (NYSE American: IGC) is developing a cannabis-based investigational drug that is being tested for the first time ever on humans in an FDA-approved study (https://ibn.fm/qsc42). The company is developing its…

FridayMar 03, 2023 9:00 am

HeartBeam Inc. (NASDAQ: BEAT) CEO Spotlighted in Interview on Making a Positive Social Impact

During interview, Vajdic recounts first steps of journey in the United States CEO points to key lessons he learned that helped him found HeartBeam The company has developed the first and only 3D-vector 12-lead electrocardiogram (“ECG”) platform for heart attack detection anytime, anywhere Growing up in Yugoslavia (now Serbia) as the only child of a well-known surgeon, HeartBeam (NASDAQ: BEAT) CEO and founder Branislav Vajdic, PhD, felt some pressure to study medicine and follow in his father’s footsteps. One day, at his father’s insistence, Vajdic observed a surgery — and fainted the moment he saw the first drop of blood.…

ThursdayMar 02, 2023 12:00 pm

Study Finds Organ Transplant Recipients Undervaccinated

A recent study has revealed that organ transplant patients of lower socioeconomic status are likely to be unvaccinated against pneumococcus and influenza. The study also found that area of residence affected whether or not solid organ transplant patients were suitably vaccinated against these two diseases. It is extremely crucial that patients who are set to receive solid organs be adequately vaccinated against Streptococcus pneumonia and influenza because these patients are immunosuppressed. Since they are on immunosuppressants, solid organ transplant patients may find it hard to fight off even simple infections such as the common cold. These patients are more likely…

ThursdayMar 02, 2023 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Nano-sized Molecules Show Powerful Impact in Preclinical Studies

BiondVax Pharmaceuticals is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products The company’s alpaca-derived nanosized antibodies (“NanoAbs”) exhibit superior valuable competitive advantages over commercially available monoclonal antibodies (“mAbs”), including better specificity and affinity to the target, hyper-thermostability, and potential for more effective and convenient routes of administration Preclinical in vivo data have shown its lead drug candidate, the inhaled anti-SARS-CoV-2 NanoAb, led to a significantly shorter and milder illness, virtually eliminated the virus from the lungs, and effectively prevented illness when administered prophylactically BiondVax aims to fill the void in COVID-19 therapeutics and is forging ahead…

WednesdayMar 01, 2023 11:09 am

Study Finds Chronic Pain Increases Risk of Developing Dementia

Chronic pain is a long-standing pain that occurs together with another chronic illness such as arthritis or cancer. Chronic pain has been linked to depression, anxiety, restrictions in mobility and daily activities, increased health care costs, poor quality of life and dependence on opioids. Now, new research has found that an individual’s risk of cognitive decline and dementia heightens if they suffer from chronic pain that lasts for more than three months. The study was carried out by researchers at the Chinese Academy of Sciences in Beijing. Professor Tu Yiheng, who was the study’s corresponding author, is a psychology professor…